Clinical Trial Update: Point-of-care Urine Monitoring of Adherence: Testing a Real-Time Urine Assay of Tenofovir in PrEP [NA]

View source ↗

Summary

A completed trial evaluating a point-of-care urine assay to monitor adherence to HIV PrEP by detecting Tenofovir in urine; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: University of California, San Francisco | Conditions: Risk Reduction | NA | Status: COMPLETED | Results posted: 2025-10-27